LIF and diabetes mellitus: There have been studies assessing the expression of LIF and VEGFA as implantation modulators (7, 13, 14); however, the expression changes of these molecules in diabetic conditions and the effects of diabetes treatment drugs on the endometrial expression of these molecules have not been well-understood.